University of Aberdeen logo

AURA - Aberdeen University Research Archive

 

Low-dose oral theophylline combined with inhaled corticosteroids for people with chronic obstructive pulmonary disease and high risk of exacerbations : a RCT

Simple item page
dc.contributor.authorDevereux, Graham
dc.contributor.authorCotton, Seonaidh
dc.contributor.authorFielding, Shona
dc.contributor.authorMcMeekin, Nicola
dc.contributor.authorBarnes, Peter J.
dc.contributor.authorBriggs, Andy
dc.contributor.authorBurns, Graham
dc.contributor.authorChaudhuri, Rekha
dc.contributor.authorChrystyn, Henry
dc.contributor.authorDavies, Lisa
dc.contributor.authorSoyza, Anthony De
dc.contributor.authorGompertz, Simon
dc.contributor.authorHaughney, John
dc.contributor.authorInnes, Karen
dc.contributor.authorKaniewska, Joanna
dc.contributor.authorLee, Amanda
dc.contributor.authorMorice, Alyn
dc.contributor.authorNorrie, John
dc.contributor.authorSullivan, Anita
dc.contributor.authorWilson, Andrew
dc.contributor.authorPrice, David
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Grampian Data Safe Haven (DaSH)en
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Centre for Healthcare Randomised Trials (CHaRT)en
dc.contributor.institutionUniversity of Aberdeen.Aberdeen Centre for Evaluationen
dc.contributor.institutionUniversity of Aberdeen.Medicine, Medical Sciences & Nutritionen
dc.contributor.institutionUniversity of Aberdeen.Medical Statisticsen
dc.date.accessioned2019-08-23T10:20:06Z
dc.date.available2019-08-23T10:20:06Z
dc.date.issued2019-07-31
dc.descriptionAcknowledgements We would like to thank all the participants who took part in the trial. We are grateful to all the staff at recruitment sites who facilitated identification, recruitment and follow-up of study participants (listed below). We are also grateful to other general practices and organisations that acted as PICs for the trial and practices that provided outcome data for trial participants who were unable to attend for follow-up. We could not have completed the trial without the ongoing support of local and primary care research networks: -NHS Research Scotland Primary Care Network (formerly Scottish Primary Care Research Network) – Amanda Cardy, Samantha Holden, Tracy Ibbotson, Yvonne McIlvenna, Marie Pitkethly, Janice Reid, Kim Stringer -North of England Commissioning Support (NECS) – Jeanette Dixon, Jill Ducker, Shona Haining, Gillian Johnson, Rachel Nixon, Norah Phipps, Cheryl Rigg - NIHR CRN South West Peninsula – Cate Atkins, Helen Clough, Tania Crabb, Patricia Hollway, Sara McNamara, Lisa Treeby, Lorraine Underwood - NIHR CRN Eastern – Lynne Baker, Brenda DeBoys, Kim Fell, Fenglin Guo, Emily Ikelle, Helen Jung, Heather Leishman, Rachel Lister, Lynn Mather, Cristina Page, Barbara Stewart - NIHR CRN Wessex Primary Care – Christine Brown - NIHR CRN Yorkshire and Humber – Carla Bratten -NIHR CRN North Thames – Mandy Austin, Carole Bartlett, Carol Keel, Helen McIver, Lucy Peppiatt. We thank Nadia Lewis-Burke for invaluable assistance in data checking. We are grateful to Georgia Mannion-Krase, Andrea Fraser and Lana Mitchell for their secretarial and data co-ordination support. We are grateful to Kirsty McCormack for her help and advice in developing the grant proposal. We thank Gladys McPherson, Mark Forrest and the programming team in CHaRT for developing and maintaining the trial website. We also thank Juliette Snow, Ruth Speedie and Rachel West for their help with contracting, and Louise Cotterell and Glenys Milton for their help in managing the budget. We are grateful for the guidance and support of the TSC (chairperson: Bill McNee; independent members: Matt Sydes, Mike Thomas, Alister Laird, Marion Middler) and the DMC chairperson: Hilary Pinnock; independent members: Chris Weir, Michael Steiner). We are also grateful to Bev Wears (British Lung Foundation) and Jacqueline Waters for helpful comments on early drafts of the trial documentation. We acknowledge Napp Pharmaceuticals Ltd for providing the trial drug (Uniphyllin, 200-mg modifiedrelease tablets) free of charge for use in the trial. The Health Services Research Unit and the Health Economics Research Unit are core funded by the Chief Scientist Office of the Scottish Government Health and Social Care Directorate.en
dc.description.statusPeer revieweden
dc.format.extent146
dc.format.extent1184057
dc.identifier146925854
dc.identifier46631608-7f0a-46ad-b034-56407a5be096
dc.identifier85070488577
dc.identifier31343402
dc.identifier000476990400001
dc.identifier.citationDevereux, G, Cotton, S, Fielding, S, McMeekin, N, Barnes, P J, Briggs, A, Burns, G, Chaudhuri, R, Chrystyn, H, Davies, L, Soyza, A D, Gompertz, S, Haughney, J, Innes, K, Kaniewska, J, Lee, A, Morice, A, Norrie, J, Sullivan, A, Wilson, A & Price, D 2019, 'Low-dose oral theophylline combined with inhaled corticosteroids for people with chronic obstructive pulmonary disease and high risk of exacerbations : a RCT', Health technology assessment (Winchester, England), vol. 23, no. 37, pp. 1-146. https://doi.org/10.3310/hta23370en
dc.identifier.doi10.3310/hta23370
dc.identifier.iss37en
dc.identifier.issn1366-5278
dc.identifier.otherORCID: /0000-0001-8512-4368/work/95223112
dc.identifier.otherORCID: /0000-0002-4865-9061/work/159078075
dc.identifier.urihttp://hdl.handle.net/2164/12765
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85070488577&partnerID=8YFLogxKen
dc.identifier.vol23en
dc.language.isoeng
dc.relation.ispartofHealth technology assessment (Winchester, England)en
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectCOPDen
dc.subjectEXACERBATIONen
dc.subjectINHALED CORTICOSTEROIDSen
dc.subjectRANDOMISED CONTROLLED TRIALen
dc.subjectTHEOPHYLLINEen
dc.subjectCOST-EFFECTIVENESSen
dc.subjectHISTONE DEACETYLASE ACTIVITYen
dc.subjectORAL THEOPHYLLINEen
dc.subjectLUNG-FUNCTIONen
dc.subjectAIRWAY INFLAMMATIONen
dc.subjectEXACERBATION FREQUENCYen
dc.subjectINHALED FLUTICASONEen
dc.subjectLOW-DOSE THEOPHYLLINEen
dc.subjectOBSTRUCTIVE PULMONARY-DISEASEen
dc.subjectCOPD PATIENTSen
dc.subjectR Medicineen
dc.subjectHealth Policyen
dc.subjectChief Scientist Office (CSO)en
dc.subject.lccRen
dc.titleLow-dose oral theophylline combined with inhaled corticosteroids for people with chronic obstructive pulmonary disease and high risk of exacerbations : a RCTen
dc.typeJournal articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
HTA_23_37_23370_VOR.pdf
Size:
1.13 MB
Format:
Adobe Portable Document Format
Download

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
8.29 KB
Format:
Plain Text
Description:
Download

Collections

All research
Applied Health Sciences research
University Office research